BioNTech SE (BNTX) Change in Taxes (2020 - 2025)
BioNTech SE's (BNTX) quarterly Change in Taxes came in at $47.1 million in Q4 2025, up 122.24% year-on-year from $21.2 million in Q4 2024, and up 520.07% quarter-over-quarter from -$11.2 million in Q3 2025.
BioNTech SE (BNTX) Change in Taxes (2020 - 2025) Analysis & Trends
BioNTech SE has disclosed Change in Taxes across 6 years of filings, most recently posting $47.1 million for Q4 2025.
- Change in Taxes for Q4 2025 came in at $47.1 million, up 122.24% year-over-year; the trailing twelve-month figure through Dec 2025 was -$193.0 million (down 28.76% YoY), and the FY2025 annual result was $4.3 million, up 101.03% from the prior year.
- Change in Taxes came in at $47.1 million for Q4 2025 at BioNTech SE, up from -$11.2 million in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $476.2 million in Q2 2023 to a low of -$4.0 billion in Q4 2021.
- The 5-year median for Change in Taxes is -$11.2 million (2025), against an average of -$502.5 million.
- Across the five-year window, Change in Taxes slumped 473829315464.91% in 2021 and jumped 122.24% in 2025, its largest moves.
- BioNTech SE's Change in Taxes stood at -$4.0 billion in 2021, then surged by 64.21% to -$1.4 billion in 2022, then surged by 99.22% to -$11.1 million in 2023, then plunged by 1809.37% to -$212.0 million in 2024, then surged by 122.24% to $47.1 million in 2025.
- The last three Change in Taxes figures came in at $47.1 million (Q4 2025), -$11.2 million (Q3 2025), and -$16.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn | 47.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 47.14 Mn |
| Dec 31, 2025 | 47.14 Mn |
| Sep 30, 2025 | -11.22 Mn |
| Sep 30, 2025 | -11.22 Mn |
| Jun 30, 2025 | -16.87 Mn |
| Jun 30, 2025 | -16.87 Mn |
| Dec 31, 2024 | -212.01 Mn |
| Dec 31, 2024 | -212.01 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 71.51 Mn |
| Jun 30, 2024 | 71.51 Mn |
| Sep 30, 2023 | -11.10 Mn |
| Sep 30, 2023 | -11.10 Mn |
| Jun 30, 2023 | 476.19 Mn |
| Jun 30, 2023 | 476.19 Mn |
| Dec 31, 2022 | -1.42 Bn |
| Dec 31, 2022 | -1.42 Bn |
| Dec 31, 2021 | -3.95 Bn |
| Dec 31, 2021 | -3.95 Bn |